by teamneuro-kinesis | Feb 6, 2020 | News
The global catheter market continues to rise at a tremendous rate growing from an estimated $37.3B in 2018 to an expected $77.7B by 2026 with an average CAGR of 9.7% over the forecast period. This dramatic increase is mostly due to the increasing prevalence of...
by teamneuro-kinesis | Feb 6, 2020 | News
Over the past two decades, advances in surgical techniques have undergone a tremendous revolution. The reasons behind these accelerated advancements can be attributed to two main processes; the improvement of medical imaging techniques and, the improvement in surgical...
by teamneuro-kinesis | Feb 19, 2020 | News
As part of the on-going pre-commercialization process for the Neuro-Kinesis (NK) SmartBrain Retractor, Frost & Sullivan was engaged to provide the NK Management Team a revenue forecast study in order to assess current brain retractor technology, surgical use...
by teamneuro-kinesis | Feb 19, 2020 | News
A Good Laboratory Practice (GLP) animal study to certify the Neuro-Kinesis Catheter Guidance Imaging and Control (CGCI) system has been completed. The GLP study was conducted in preparation for the first human studies to be done at Hospital Universitario La Paz in...
by teamneuro-kinesis | Dec 20, 2011 | News
In December of 2011, the CGCI System received CE Marking certification. CE Marking enables the commercialization of CGCI in Europe and support certification in many other parts of the world. The scope of the indication for CGCI’s CE Marking is “Design,...
by teamneuro-kinesis | Oct 20, 2011 | News
A CGCI suite has been installed at the Yonsei University Severance Hospital in Seoul, South Korea. This installation represents the first such in the Asia market. Clinical trials will be conducted at the hospital using CGCI for mapping and ablation procedures...
